SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DRSLTR - Correspondence Related to Draft Registration Statement:
SEC Accession No. 0000950123-20-001609
Filing Date
2020-02-12
Accepted
2020-02-12 13:52:48
Documents
3

Document Format Files

Seq Description Document Type Size
1 filename1.htm DRSLTR 64264
2 GRAPHIC g846749img1.jpg GRAPHIC 5139
3 GRAPHIC g846749img2.jpg GRAPHIC 3642
  Complete submission text file 0000950123-20-001609.txt   77548
Mailing Address 1313 N. MARKET STREET SUITE 5100 WILMINGTON DE 19801
Business Address 1313 N. MARKET STREET SUITE 5100 WILMINGTON DE 19801 (857) 444-0553
Ayala Pharmaceuticals, Inc. (Filer) CIK: 0001797336 (see all company filings)

IRS No.: 823578375 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DRSLTR
SIC: 2836 Biological Products, (No Diagnostic Substances)